BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 36469125)

  • 1. A systematic review of patient-reported outcome measures for advanced skin cancer patients.
    Reinhardt ME; Sun T; Pan CX; Schmults CD; Lee EH; Waldman AB
    Arch Dermatol Res; 2023 Aug; 315(6):1473-1480. PubMed ID: 36469125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality of life measurement in skin cancer patients: literature review and position paper of the European Academy of Dermatology and Venereology Task Forces on Quality of Life and Patient Oriented Outcomes, Melanoma and Non-Melanoma Skin Cancer.
    Chernyshov PV; Lallas A; Tomas-Aragones L; Arenbergerova M; Samimi M; Manolache L; Svensson A; Marron SE; Sampogna F; Spillekom-vanKoulil S; Bewley A; Forsea AM; Jemec GB; Szepietowski JC; Augustin M; Finlay AY
    J Eur Acad Dermatol Venereol; 2019 May; 33(5):816-827. PubMed ID: 30963614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic review of patient-reported outcome measures in the surgical treatment of patients with esophageal cancer.
    Straatman J; Joosten PJ; Terwee CB; Cuesta MA; Jansma EP; van der Peet DL
    Dis Esophagus; 2016 Oct; 29(7):760-772. PubMed ID: 26471471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementation of patient-reported outcome measures and patient-reported experience measures in melanoma clinical quality registries: a systematic review.
    Blood Z; Tran A; Caleo L; Saw R; Dieng M; Shackleton M; Soyer HP; Arnold C; Mann GJ; Morton RL
    BMJ Open; 2021 Feb; 11(2):e040751. PubMed ID: 33574144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing the quality of patient-reported outcome measurements for gynecological cancers: a systematic review.
    Moss CL; Guerrero-Urbano T; White I; Taylor B; Kristeleit R; Montes A; Fox L; Beyer K; Sztankay M; Ratti MM; Sisca ES; Derevianko A; MacLennan S; Wood N; Wintner LM; Van Hemelrijck M
    Future Oncol; 2023 Mar; 19(9):663-678. PubMed ID: 37128990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Standardising the Assessment of Patient-reported Outcome Measures in Localised Prostate Cancer. A Systematic Review.
    Ratti MM; Gandaglia G; Alleva E; Leardini L; Sisca ES; Derevianko A; Furnari F; Mazzoleni Ferracini S; Beyer K; Moss C; Pellegrino F; Sorce G; Barletta F; Scuderi S; Omar MI; MacLennan S; Williamson PR; Zong J; MacLennan SJ; Mottet N; Cornford P; Aiyegbusi OL; Van Hemelrijck M; N'Dow J; Briganti A;
    Eur Urol Oncol; 2022 Apr; 5(2):153-163. PubMed ID: 34785188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A systematic review of patient-reported outcome instruments of nonmelanoma skin cancer in the dermatologic population.
    Lee EH; Klassen AF; Nehal KS; Cano SJ; Waters J; Pusic AL
    J Am Acad Dermatol; 2013 Aug; 69(2):e59-67. PubMed ID: 23102770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health-related quality of life in women with breast cancer: a review of measures.
    Salas M; Mordin M; Castro C; Islam Z; Tu N; Hackshaw MD
    BMC Cancer; 2022 Jan; 22(1):66. PubMed ID: 35033009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A structured review of patient-reported outcome measures for patients with skin cancer, 2013.
    Gibbons E; Casañas i Comabella C; Fitzpatrick R
    Br J Dermatol; 2013 Jun; 168(6):1176-86. PubMed ID: 23488455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validated Instruments of Quality of Life (QOL) in Patients With Acute Myeloid Leukemia (AML) and Other Cancers.
    Salas M; Henderson M; Wientzek-Fleischmann A; Islam Z; Tu N; Bilitou A; Elsharkawy M; Stellmacher U
    Front Pharmacol; 2020; 11():1109. PubMed ID: 32792948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mapping EORTC QLQ-C30 and FACT-G onto EQ-5D-5L index for patients with cancer.
    Hagiwara Y; Shiroiwa T; Taira N; Kawahara T; Konomura K; Noto S; Fukuda T; Shimozuma K
    Health Qual Life Outcomes; 2020 Nov; 18(1):354. PubMed ID: 33143687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing quality of life in palliative care settings: head-to-head comparison of four patient-reported outcome measures (EORTC QLQ-C15-PAL, FACT-Pal, FACT-Pal-14, FACT-G7).
    King MT; Agar M; Currow DC; Hardy J; Fazekas B; McCaffrey N
    Support Care Cancer; 2020 Jan; 28(1):141-153. PubMed ID: 30993452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient-reported outcome measures in studies of myelodysplastic syndromes and acute myeloid leukemia: Literature review and landscape analysis.
    Stauder R; Lambert J; Desruol-Allardin S; Savre I; Gaugler L; Stojkov I; Siebert U; Chevrou-Séverac H
    Eur J Haematol; 2020 May; 104(5):476-487. PubMed ID: 31985078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of the Skin Cancer Quality of Life Impact Tool (SCQOLIT) - a feasibility study in non-melanoma skin cancer.
    Wali GN; Gibbons E; Kelly L; Reed JR; Matin RN
    J Eur Acad Dermatol Venereol; 2020 Mar; 34(3):491-501. PubMed ID: 31419362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-cultural development of a quality-of-life measure for patients with melanoma: phase 3 testing of an EORTC Melanoma Module.
    Winstanley JB; Young TE; Boyle FM; Bergenmar M; Bottomley A; Burmeister B; Campana LG; Garioch JJ; King M; Nikolic DV; van de Poll-Franse LV; Saw R; Thompson JF; White EG;
    Melanoma Res; 2015 Feb; 25(1):47-58. PubMed ID: 25325247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial.
    Harrington KJ; Ferris RL; Blumenschein G; Colevas AD; Fayette J; Licitra L; Kasper S; Even C; Vokes EE; Worden F; Saba NF; Kiyota N; Haddad R; Tahara M; Grünwald V; Shaw JW; Monga M; Lynch M; Taylor F; DeRosa M; Morrissey L; Cocks K; Gillison ML; Guigay J
    Lancet Oncol; 2017 Aug; 18(8):1104-1115. PubMed ID: 28651929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient-reported outcome measures in nonmelanoma skin cancer of the face: a systematic review.
    Bates AS; Davis CR; Takwale A; Knepil GJ
    Br J Dermatol; 2013 Jun; 168(6):1187-94. PubMed ID: 23387431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Landscape of Health-Related Quality of Life in Patients With Early-Stage Pancreatic Cancer Receiving Adjuvant or Neoadjuvant Chemotherapy: A Systematic Literature Review.
    Macarulla T; Hendifar AE; Li CP; Reni M; Riess H; Tempero MA; Dueck AC; Botteman MF; Deshpande CG; Lucas EJ; Oh DY
    Pancreas; 2020 Mar; 49(3):393-407. PubMed ID: 32132518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring quality of life among head-and-neck cancer patients in Western India using European organization for research and treatment of cancer questionnaires.
    Parkar S; Sharma A; Shah M
    J Cancer Res Ther; 2022; 18(4):990-996. PubMed ID: 36149151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.